Evidence map›Paper›PMID 41473440›Full record

ArticleFrontiers in oncology2025

A PET-CT study of the uptake of labeled aptamers [

Andrey A Postnov, Igor N Pronin, Nina B Vikhrova, Diana B Kalaeva, Elena V Pyzhik, Alexey A Lipengolts, Alexander V Revishchin, Fatima M Dzarieva, Yahya A Sliman, Andrey V Golovin and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Andrey A PostnovFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Igor N ProninFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Nina B VikhrovaFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Diana B KalaevaFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Elena V PyzhikFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Alexey A LipengoltsNational Research Nuclear University MEPhI, Moscow, Russia.
Alexander V RevishchinInstitute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences, Moscow, Russia.
Fatima M DzarievaFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Yahya A SlimanFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Andrey V GolovinFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Vladimir A KorshunFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Vladimir A BrylevFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Vsevolod A Skribitsky"N.N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Yulia A Finogenova"N.N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Kristina E Shpakova"N.N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Elena Yu Grigorieva"N.N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Anna I AlekseevaFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Anna V Smirnova"N.N. Blokhin National Medical Research Center of Oncology" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Alexey M KopylovFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Galina V PavlovaFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.
Dmitry Yu UsachevFederal State Autonomous Institution "N.N. Burdenko National Medical Research Center of Neurosurgery" of the Ministry of Health of the Russian Federation, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Objectives: The ability to predict the values of immunohistochemical (IHC) biomarkers noninvasively for brain tumors is an important diagnostic task, accelerating the medical decision-making process and reducing the burden on the patient. In this work, the epidermal growth factor receptor (EGFR) is considered as a biomarker, the expression of which is associated with accelerated division and proliferation of cancer cells. The aim of this work is to study the binding of [ Methods: The tissue model of rat 101.8 glioblastoma was transplanted to Wistar rats (n=14). Rats with developed tumors underwent successive PET-CT examinations with [ Results: Both [ Conclusions: This study demonstrates that both [

Indexed as

animal PET-CTEGFRglioblastomaglioma diagnosticsGol1 aptamerGR20 aptamerrat 101.8 glioblastoma model

Identifiers

PMID41473440
PMCPMC12745220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.